Self-degradable sustained-release material for cardiovascular stent coating and preparation method of sustained-release material
A slow-release material and cardiovascular technology, applied in coating, medical science, surgery, etc., can solve the problems of expensive catalyst and high preparation cost, reduce pain and economic burden, high preparation efficiency, and good controllable degradation effect. Effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0025] A slow-release material for self-degrading cardiovascular stent coating, characterized in that it comprises the following components in parts by weight: 2,5-bischloromethyl-1,3,4-oxadiazole / 30 parts of 2,6-diaminopurine nucleoside polycondensate, 20 parts of hyperbranched polyamino acid, and 2 parts of 1,4-cyclohexanedimethanol bis(3,4-epoxycyclohexanecarboxylate).
[0026] The preparation method of the 2,5-bischloromethyl-1,3,4-oxadiazole / 2,6-diaminopurine nucleoside polycondensate is characterized in that it comprises the following steps: 2,5-bis Chloromethyl-1,3,4-oxadiazole, 2,6-diaminopurine nucleoside, and basic catalyst were added to the high boiling point solvent, stirred and reacted at 40°C for 3 hours, and then precipitated in water, and The solvent is removed by rotary evaporation to obtain 2,5-bischloromethyl-1,3,4-oxadiazole / 2,6-diaminopurine nucleoside polycondensate; the 2,5-bischloromethyl-1, The mol ratio of 3,4-oxadiazole, 2,6-diaminopurine nucleosid...
Embodiment 2
[0032] A slow-release material for self-degrading cardiovascular stent coating, characterized in that it comprises the following components in parts by weight: 2,5-bischloromethyl-1,3,4-oxadiazole / 33 parts of 2,6-diaminopurine nucleoside polycondensate, 22 parts of hyperbranched polyamino acid, and 3 parts of 1,4-cyclohexanedimethanol bis(3,4-epoxycyclohexanecarboxylate).
[0033] The preparation method of the 2,5-bischloromethyl-1,3,4-oxadiazole / 2,6-diaminopurine nucleoside polycondensate is characterized in that it comprises the following steps: 2,5-bis Chloromethyl-1,3,4-oxadiazole, 2,6-diaminopurine nucleoside, and basic catalyst were added to the high boiling point solvent, stirred and reacted at 45°C for 3.5 hours, and then precipitated in water, and The solvent is removed by rotary evaporation to obtain 2,5-bischloromethyl-1,3,4-oxadiazole / 2,6-diaminopurine nucleoside polycondensate; the 2,5-bischloromethyl-1, The mol ratio of 3,4-oxadiazole, 2,6-diaminopurine nucleos...
Embodiment 3
[0039] A slow-release material for self-degrading cardiovascular stent coating, characterized in that it comprises the following components in parts by weight: 2,5-bischloromethyl-1,3,4-oxadiazole / 35 parts of 2,6-diaminopurine nucleoside polycondensate, 25 parts of hyperbranched polyamino acid, 3.5 parts of 1,4-cyclohexanedimethanol bis(3,4-epoxycyclohexanecarboxylate).
[0040] The preparation method of the 2,5-bischloromethyl-1,3,4-oxadiazole / 2,6-diaminopurine nucleoside polycondensate is characterized in that it comprises the following steps: 2,5-bis Chloromethyl-1,3,4-oxadiazole, 2,6-diaminopurine nucleoside, and basic catalyst were added to the high boiling point solvent, stirred and reacted at 50°C for 4 hours, and then precipitated in water, and The solvent is removed by rotary evaporation to obtain 2,5-bischloromethyl-1,3,4-oxadiazole / 2,6-diaminopurine nucleoside polycondensate; the 2,5-bischloromethyl-1, The molar ratio of 3,4-oxadiazole, 2,6-diaminopurine nucleoside,...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com